An Appraisal of the Efficacy of the Antiviral R 61837 in Rhinovirus Infections in Human Volunteers
- 1 October 1990
- journal article
- Published by SAGE Publications in Antiviral Chemistry and Chemotherapy
- Vol. 1 (5) , 279-283
- https://doi.org/10.1177/095632029000100501
Abstract
The efficacy of the antiviral R 61837 in experimental colds in three previously reported volunteer trials and one new trial is reviewed here. It was dissolved in a new vehicle, hydroxy-β-cyclodextrin, and used as a nasal spray. A substantial reduction in illness occurred when given prophylactically and during the incubation period but not when used therapeutically.Keywords
This publication has 9 references indexed in Scilit:
- Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837)Antimicrobial Agents and Chemotherapy, 1989
- Drug resistant rhinoviruses from the nose of experimentally treated volunteersArchiv für die gesamte Virusforschung, 1989
- In vitro activity of R 61837, a new antirhinovirus compoundArchiv für die gesamte Virusforschung, 1988
- Chemotherapy of rhinovirus coldsAntimicrobial Agents and Chemotherapy, 1988
- A ‘new’ generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactionsAntiviral Research, 1987
- Failure of intranasally administered 4?, 6-dichloroflavan to protect against rhinovirus infection in manArchiv für die gesamte Virusforschung, 1987
- The Site of Attachment in Human Rhinovirus 14 for Antiviral Agents That Inhibit UncoatingScience, 1986
- Prevention and treatment of experimental influenza A virus infection in volunteers with a new antiviral ICI 130,685Journal of Antimicrobial Chemotherapy, 1986
- Intranasal Interferon- 2, Treatment of Experimental Rhinoviral ColdsThe Journal of Infectious Diseases, 1984